Form 4: Rocket Pharmaceuticals' General Counsel Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Martin Wilson, General Counsel of Rocket Pharmaceuticals, sold 946 shares of common stock on May 16, 2025, to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- On May 16, 2025, Martin Wilson, the General Counsel of Rocket Pharmaceuticals, sold 946 shares of the company's common stock.
- The sale was executed at a price of $6.528 per share.
- This transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Wilson directly owns 149,750 shares of Rocket Pharmaceuticals' common stock, including RSUs that convert to common stock on a one-for-one basis.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The transaction is a routine sale of shares to cover tax obligations, which is a common practice and doesn't necessarily reflect a positive or negative outlook on the company.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.
Key Dates
| Date | Description |
|---|---|
| 05/16/2025 | Date of the transaction: Martin Wilson sold shares of Rocket Pharmaceuticals' common stock. |
| 05/20/2025 | Date of signature on the Form 4 filing. |
Keywords
Rocket Pharmaceuticals, Martin Wilson, Form 4, share sale, General Counsel, RCKT, Restricted Stock Units, tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.